iRadimed
IRMD
49,06 €
Share price
0.19%
Change (1 day)
23.79%
Change (1 year)
Categories
P/S ratio for iRadimed (IRMD)
P/S ratio as of March 2025 (TTM): 9.19
According to iRadimed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.76. At the end of 2024 the company had a P/S ratio of 9.46.
P/S ratio history for iRadimed from 2014 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 9.46 | 3.65% |
| 2023 | 9.13 | 36.85% |
| 2022 | 6.67 | -51.89% |
| 2021 | 13.9 | 56.68% |
| 2020 | 8.85 | 23.89% |
| 2019 | 7.14 | -19.12% |
| 2018 | 8.83 | 27.46% |
| 2017 | 6.93 | 89.35% |
| 2016 | 3.66 | -63.1% |
| 2015 | 9.91 | 11.24% |
| 2014 | 8.91 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 3.66 | -60.18% | 🇺🇸 USA |
 | 1.70 | -81.51% | 🇺🇸 USA |
 | 7.13 | -22.49% | 🇺🇸 USA |
 | 7.32 | -20.42% | 🇺🇸 USA |